Pope Leo early-stage adenocarcinoma is a reminder that lung nodules often cause no symptoms and that people who never smoked can get lung cancer.
|Articles|March 5, 2008
Congress questions celebrity endorsements, FDA oversight of DTC drug ads
The campaign against drug TV advertising and marketing seems to be accelerating in Washington and around the country. The latest salvo comes from leaders of the House Energy & Commerce Committee who want information from pharmaceutical companies and the Food and Drug Administration about questionable marketing campaigns.
Advertisement
The campaign against drug TV advertising and marketing seems to be accelerating in Washington and around the country. The latest salvo comes from leaders of the House Energy & Commerce Committee who want information from pharmaceutical companies and the Food and Drug Administration about questionable marketing campaigns.
E&C Chairman John Dingell and Oversight Subcommittee Chairman Bart Stupak, both Michigan Democrats, are questioning the use of celebrity spokesman Dr. Robert Jarvik in Pfizer commercials for Lipitor (atorvastatin). The legislators consider the ads misleading because Jarvik is not a heart specialist and didn’t perform the energetic rowing shown in TV commercials featuring his comments.
Celebrity endorsements are problematic for any DTC advertising, according to the investigators. However, they consider it particularly troubling to use stunt doubles in ads designed to emphasize a medicine’s powerful effectiveness.
The crack-down on Lipitor ads by the House committee follows their investigation into ads for Vytorin promoting the drugs effectiveness, which subsequently came into question. The committee demanded that FDA provide it with all agency records relating to print, broadcast and internet advertising for Vytorin, which brought in boxes of documents and disks. In addition, co-marketers Merck and Schering-Plough halted consumer advertising of Vytorin.
Advertisement
Related to this article
Young-onset lung cancer often strikes nonsmokers, and current screening based on smoking is not likely to find it, says Singhi, an assistant professor at UT MD Anderson Cancer Center in Houston. New risk-based screening, liquid biopsies, and breath tests aim earlier detection.
Rex Hoffman, M.D., MBA, says physician shortages and burnout are the most underestimated pressures on health system.
Rex Hoffman, M.D., MBA, of Providence Holy Cross walks through a CMO’s day in a hospital that often runs 85% to 100% full, from safety huddles to discharges.
On average, caregivers want to see their children with ADHD fall asleep 30 minutes faster, but the best sleep treatments average approximately 20 minutes, a new survey study found.
Research findings presented at CHEST meeting show COPD hospital readmission drops with discharge checklists and navigation. Other research suggests targeting readmission prevention efforts on patents discharged to post-acute facilities.
As the pharmacist pipeline tightens, leaders from UC Davis Health, UCSF Health, and Sutter Health say financial sustainability now depends as much on capacity as on cost.
GLP-1 use in adults 65 and older with MASLD was linked to a 45% lower risk of death, and a 28% lower risk of hepatic decompensation, a new Houston Methodist Research Institute study shows.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Rex Hoffman, M.D., on physician burnout and collaborative leadership | HSES 2026
2
GLP-1 therapy tied to lower mortality and liver decompensation in older adults with MASLD
3
Preventing hospital readmissions among patients with COPD. Here are some ideas on how to do that | CHEST 2026
4
Algia Pharma completes investigational drug toxicology study for non-opioid acute pain regimen AlgiaPak
5